THR-β agonist 3

THR-β agonist 3

• CAS Number: 2656400-84-7
• UNSPSC Description: THR-β agonist 3 is a potent agonist of THR-β. THR-β agonist 3 has the potential for the research of metabolic diseases such as obesity, hyperlipidemia, hypercholesterolemia, diabetes and other conditions such as steatosis and non-alcoholic steatohepatitis (NASH), atherosclerosis and other related conditions and diseases (extracted from patent WO2021129827A1, compound 6)[1].
• Target Antigen: Others
• Type: Reference compound
• Related Pathways: Others
• Applications: Metabolism-sugar/lipid metabolism
• Field of Research: Metabolic Disease
• Assay Protocol: https://www.medchemexpress.com/thr-β-agonist-3.html
• Solubility: 10 mM in DMSO
• Smiles: CC1=C2[C@](C3=CC(C(C)C)=C(C=C3)O)([H])CCC2=CC(OC[P@@]4(O[C@@](C5=CC(Cl)=CC=C5)([H])CCO4)=O)=C1
• Molecular Weight: 526.99
• References & Citations: [1]Li Peng, et al. Benzo-fused ring compounds. Patent WO2021129827A1.
• Shipping Conditions: Room temperature
• Clinical Information: No Development Reported